Tag Archives: biophotonics

Smart Needle

Smart needle uses IOT in brain surgery

The smart needle was developed by researchers at the University of Adelaide in South Australia and uses a tiny camera to identify at-risk blood vessels.

The probe, which is the size of a human hair, uses an infrared light to look through the brain.

It then uses the Internet of Things to send the information to a computer in real-time and alerts doctors of any abnormalities.

The project was a collaboration with the University of Western Australia and Sir Charles Gairdner Hospital where a six-month pilot trial of the smart needle was run.

Research leader and Chair of the University of Adelaide’s Centre of Excellence for Nanoscale BioPhotonics Robert McLaughlin says researchers are also looking at other surgery applications for the device including minimally invasive surgery.

He says surgeons previously relied on scans taken prior to surgery to avoid hitting blood vessels but the smart needle is a more accurate method that highlighted their locations in real-time.

“There are about 256,000 cases of brain cancer a year and about 2.3 per cent of the time you can make a significant impact that could end in a stroke or death,” he says.

“This (smart needle) would help that … it works sort of like an ultrasound but with light instead.

“It also has smart software that takes the picture, analyses it and it can determine if what it is seeing is a blood vessel or tissue.”

Smart Needle
Professor Robert McLaughlin (right) with the smart needle.

Professor McLaughlin says the smart needle has potential to be used in other surgical procedures. 

The trial at the Sir Charles Gairdner Hospital involved 12 patients who were undergoing craniotomies.

The needle with a 200-micron wide camera was successfully able to identify blood vessels during the surgery.

Professor Christopher Lind, who led the trial, says having a needle that could see blood vessels as surgeons proceeded through the brain is a medical breakthrough.

“It will open the way for safer surgery, allowing us to do things we’ve not been able to do before,” he says.

The smart needle will be ready for formal clinical trials in 2018.

Professor McLaughlin says he hopes manufacturing of the smart needle will begin within five years.

The project was partially funded by the Australian Research Council, the National Health and Medical Research Council and the South Australian Government.

The Australia Government has committed $23 million until 2021 to encourage vital research discoveries through the Australian Research Council Centre of Excellence for Nanoscale BioPhotonics.

– Caleb Radford

This article was first published by The Lead on 20 January 2017. Read the original article here.

biophotonics

Biophotonics pioneer

Featured image above: biophotonics Professor Dayong Jin. Credit Vanessa Valenzuela Davie

Professor Dayong Jin envisions a future where portable diagnostic devices will be as ubiquitous as smartphones, where scientists can peer inside individual cells, and where diseases can be detected before they infect our bodies.

A pioneer in the emerging field of nanoscale biophotonics at the University of Technology Sydney (UTS), it’s a future Jin is working hard to create.

“The nanoscale is really the fundamental level on which biological molecules operate,” he says. “It’s the scale of the original disease.”

Jin engineers functional nanoparticles – invisible to the naked eye – which harness light to probe our cells, detect diseases and deliver drugs in perfectly measured doses.

Transforming the biomedical industry with biophotonics

Jin was recently named the Director of a new A$3.7 million Australian Research Council Industrial Transformation Hub. The hub’s objective is to develop portable diagnostic devices with vastly improved detection capabilities.

These easy-to-use devices, which incorporate nanomaterials and photonic technologies developed by Jin and his colleagues from UTS and the University of South Australia, can analyse incredibly small samples of substances including breath, saliva, urine and blood, to find markers of disease.

Jin says these point-of-care technologies will ease the burden on hospitals and align with the demands of consumers: real-time health monitoring, and faster treatment options.

“In the near future, prostate cancer patients who have gone into remission will have a handheld device at home to analyse their urine samples,” he says. “It will be able to tell them whether their cancer is recurring.”

The hub is also working with industry partners to develop an improved roadside breath-testing device for police forces to detect traces of illicit drugs.

Over its five-year lifespan, Jin expects the hub to generate a number of new portable diagnostic devices, which can be tailored to specific applications to detect everything from cancers to infectious diseases and environmental pollutants.

Super Dots diagnose diseases inside the body

Jin is also helping improve disease diagnosis from inside the body itself.

Cancers and infectious disease outbreaks all originate from a single cell, he says.

“The current challenge is that we don’t have a method to find this very rare cell from the earliest stage.”

Jin was part of an Australian research team that developed a technology known as Super Dots, which won a prestigious Eureka Prize in 2015. These nanoparticles can find a needle in a haystack, detecting individual diseased cells from a population of millions.

The particles are made from a nanocrystal material that can absorb invisible infrared light and emit higher energy, visible light, says Jin.

Once the nanoparticle has found the target cell inside the body, or a blood sample, it can be stimulated by researchers with a harmless, skin-penetrating infrared light.

The dot then emits a visible flash, which causes the diseased cell to light up.

“It’s like you have the diseased cell glowing in the darkness,” says Jin. “This allows you to achieve the ultimate detection sensitivity.”

Beyond medicine, Super Dots can be encoded with “secret signatures” and used for the anti-counterfeiting of passports, banknotes and drug labels, says Jin.

There are also applications for more efficient solar cells and 3D display screens.

Biophotonics pioneer featured video above: Superdots, WINNER 2015 Eureka Prize for Excellence in Interdisciplinary Scientific Research.Credit: Australian Museum.

Breaching the blood-brain barrier

Jin is hopeful that another class of his nanoparticles will serve as a versatile drug delivery vehicle, capable of breaching the protective blood-brain barrier.

Delivering drugs to individual neurons in the brain is a “holy grail problem” in neurological research, says Jin.

“There are many drugs already developed to treat Alzheimer’s and Parkinson’s quite effectively outside the body,” he says. “But the blood-brain barrier prevents more than 99 per cent of drugs from accessing the brain from the blood circulation system.”

Jin and his colleagues have created a library of 800 types of nanoscale drug carriers with specific shapes, sizes and surface functionality. Importantly, they have developed a process to replicate these carriers exactly, according to any design.

“We’ve solved the problem in terms of developing the material,” he says.

“If the tailored drug carrier can tell the blood-brain barrier that the carriers are the friend and not the enemy… we can open a gate into the brain.”

Super-resolution microscopy breakthrough

biophotonics
Super resolution image of the single cell nuclear membrane pores. Credit: Professor Dayong Jin.

Jin’s research has led to a recent breakthrough in the field of microscopy.

With colleagues at Georgia Institute of Technology in the US and Peking University in China, Jin has developed a simple but highly effective way to see individual cells in 3D – overcoming a major barrier. Instead of growing cells on transparent glass slides, the team grew their cells on specialised mirrors. As reflected light passed through the cell while being viewed under a super-resolution microscope, researchers could see new structures in exquisite detail.

“This simple technology is allowing us to see the details of cells that have never been seen before,” says Jin. “We can see the tiny little hole on the cell nucleus’ membrane – that hole is the entrance and exit for single molecules.

“When the cell wants to express a signal, or send a message outside the cell, this is the gateway – and we now have the tool to see what that looks like.”

By understanding how cells behave, communicate and how diseases arise inside them, researchers can develop more effective treatments.

Jin and Professor Peng Xi from Peking University hold a patent for their invention, and Jin says they are currently exploring opportunities to commercialise the technology with leading imaging companies such as Olympus and German firm Leica.

Multiculturalism trumps geography for Australia

It was love that brought Jin to Australia from his home in northeastern China, near the border with inner Mongolia. His future wife, Lisa Li, came to Sydney to study accounting in 2002, and he followed.

Jin ended up at Macquarie University in the laboratory of Dr Jim Piper, a renowned expert in lasers, optics and photonics. Under his guidance, Jin developed a system to detect trace amounts of pathogens in water.

Jin says the postgraduate scholarship in Australia was more comprehensive and generous than what was offered to his Chinese peers who chose to study in the US.

Jin says he and his family had planned on returning to China or finding a postdoctoral position in the US after his PhD, but ultimately decided to stay in Australia.

He says the decision has been good for his career: “Geographically, Australia looks like it’s isolated,” he says. “But we are actually well connected.

“The Australian research community is very multicultural, and these ‘soft connections’ have created a lot of opportunities for my research collaborations.”

Jin says multidisciplinary knowledge and collaboration is vital to realising the healthcare future he envisions – and going even further beyond.

In addition to his many breakthroughs in biophotonics, one of the prospects Jin is most excited about is that of truly personalised medicines.

At present, people with the same diseases are all treated with the same drugs, which might be totally ineffective for a proportion of the population, says Jin.

“But future medicines will have a tool to decode the unique molecular signature of a patient,” he says.

It means when two people have the same disease, they could be treated remarkably differently – with dramatically improved outcomes.

This is where we’re heading, he says.

– Myles Gough
This article on the biophotonics pioneer, Professor Dayong Jin, was first published by Australia Unlimited on 9 August 2016. Read the original article here.